Skip to main content
Caplight Logo









InSpek

InSpek

Private
PalaiseauHealthcare & Life Scienceshttps://www.inspek-solutions.com/

Last Round

Grant

Sep 25, 2024

Total Funding Raised

$6.68M

Company Overview

InSpek is a biotechnology company that develops Raman-on-chip spectroscopy sensors using photonic integrated circuits and artificial intelligence for real-time monitoring of chemical and biological processes.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Sensors

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts, Services & Consulting

AI Layer

Application

Keywords

Raman-on-chipphotonic integrated circuitsPICsbioprocess monitoringprocess analytical technologyPAToptical spectroscopychemometricssingle-use systemsreal-time sensingbiomanufacturinglab-on-a-chipsmart manufacturingindustrial iotIIoT

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

InSpek Comparables

Compare InSpek with similar companies based on industry and business-model similarity.

InSpek comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Perceptra
78%
InProcess-LSP
73%
Endress+Hauser
71%

InSpek Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 25, 2024
SeedSep 25, 2024
Pre SeedOct 19, 2021

Key People

Founding team and executive leadership

Jérôme Michon

Co-Founder & CEO

Founding Team

Ivan-Lazar Bundalo

Chief Technology Officer

Executive Team

InSpek Investors

Notable investors and investment history

InSpek investors
InvestorRounds
European Innovation Council FundGrant
SpaceFoundersSeed
BreegaSeed
QuantonationPre Seed, Seed
Wind CapitalSeed
BpifranceSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 17, 2026

    Monthly visitors increased 242% MoM.

  • Oct 18, 2024

    Grew 27% QoQ from 11 to 14 employees.

InSpek Filings

Explore SEC and related filing metadata, where available.

InSpek filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about InSpek's valuation, stock price, and market status.

Is InSpek a public or private company?

InSpek is a private company.

What is the current stock price of InSpek?

InSpek is a private company, so its shares have no public market price. Caplight tracks InSpek's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is InSpek worth (valuation)?

Valuation information for InSpek is not publicly available.

Can I buy InSpek stock?

InSpek shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was InSpek's last funding round?

InSpek's most recent funding round was Grant on September 25, 2024.

Who are the main investors in InSpek?

Key investors in InSpek include Breega, Wind Capital.

Will InSpek IPO soon?

No public IPO plans have been announced for InSpek.

How can I track InSpek secondary market activity?

Caplight tracks bids, offers, and trades in InSpek's shares on secondary markets.

Firmographic Details

HeadquartersPalaiseau
Employee Range15
Year Founded2021
Last FundingSep 25, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?